HEADER HYDROLASE 10-JUN-12 4AX6 TITLE HYPOCREA JECORINA CEL6A D221A MUTANT SOAKED WITH 6-CHLORO-4- TITLE 2 PHENYLUMBELLIFERYL-BETA-CELLOBIOSIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: EXOGLUCANASE 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 109-471; COMPND 5 SYNONYM: CBHII, CELLOBIOHYDROLASE CEL6A, 1\,4-BETA-CELLOBIOHYDROLASE, COMPND 6 EXOCELLOBIOHYDROLASE II, EXOGLUCANASE II; COMPND 7 EC: 3.2.1.91; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: TRICHODERMA REESEI; SOURCE 3 ORGANISM_TAXID: 51453; SOURCE 4 EXPRESSION_SYSTEM: TRICHODERMA REESEI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 51453 KEYWDS HYDROLASE, HYDROLASE(O-GLYCOSYL), GLYCOSIDASE, GLYCOSIDE HYDROLASE, KEYWDS 2 GH6, CLPHUFG2, CELLULASE, CELLOBIOHYDROLASE, GLYCOPROTEIN, KEYWDS 3 FLUOROGENIC SUBSTRATE EXPDTA X-RAY DIFFRACTION AUTHOR M.WU,W.NERINCKX,K.PIENS,T.ISHIDA,H.HANSSON,J.STAHLBERG,M.SANDGREN REVDAT 3 20-DEC-23 4AX6 1 HETSYN REVDAT 2 29-JUL-20 4AX6 1 COMPND REMARK HETNAM LINK REVDAT 2 2 1 SITE ATOM REVDAT 1 23-JAN-13 4AX6 0 JRNL AUTH M.WU,W.NERINCKX,K.PIENS,T.ISHIDA,H.HANSSON,M.SANDGREN, JRNL AUTH 2 J.STAHLBERG JRNL TITL RATIONAL DESIGN, SYNTHESIS, EVALUATION AND ENZYME-SUBSTRATE JRNL TITL 2 STRUCTURES OF IMPROVED FLUOROGENIC SUBSTRATES FOR FAMILY 6 JRNL TITL 3 GLYCOSIDE HYDROLASES. JRNL REF FEBS J. V. 280 184 2013 JRNL REFN ISSN 1742-464X JRNL PMID 23137336 JRNL DOI 10.1111/FEBS.12060 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 64.17 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 26231 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1379 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1946 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.08 REMARK 3 BIN R VALUE (WORKING SET) : 0.2470 REMARK 3 BIN FREE R VALUE SET COUNT : 92 REMARK 3 BIN FREE R VALUE : 0.3190 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5488 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 270 REMARK 3 SOLVENT ATOMS : 544 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.10000 REMARK 3 B22 (A**2) : 0.03000 REMARK 3 B33 (A**2) : 0.60000 REMARK 3 B12 (A**2) : -0.28000 REMARK 3 B13 (A**2) : -0.25000 REMARK 3 B23 (A**2) : 1.64000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 1.205 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.294 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.219 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.264 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.908 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.857 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5946 ; 0.006 ; 0.020 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8178 ; 0.984 ; 1.995 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 728 ; 4.567 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 250 ;36.827 ;25.040 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 776 ;11.844 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ; 9.251 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 932 ; 0.060 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4554 ; 0.004 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4AX6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-JUN-12. REMARK 100 THE DEPOSITION ID IS D_1290052457. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31621 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 35.700 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.3 REMARK 200 DATA REDUNDANCY : 3.800 REMARK 200 R MERGE (I) : 0.20000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1HGY REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 5000 MONOMETHYL ETHER (FLUKA) REMARK 280 AND 20 MM SODIUM MES BUFFER, PH 6.0 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASP 245 TO ALA REMARK 400 ENGINEERED RESIDUE IN CHAIN B, ASP 245 TO ALA REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 169 74.35 -154.29 REMARK 500 ASP A 170 37.29 -151.18 REMARK 500 ASP A 189 49.55 -108.57 REMARK 500 GLU A 219 81.54 45.71 REMARK 500 ALA A 221 -23.23 71.27 REMARK 500 TRP A 269 -79.10 -105.62 REMARK 500 ASN A 305 -166.51 -115.19 REMARK 500 ASN A 369 53.79 39.51 REMARK 500 ASN B 158 47.43 -104.21 REMARK 500 ASN B 161 55.86 -141.99 REMARK 500 ASP B 170 40.86 -154.02 REMARK 500 ASP B 189 56.03 -106.92 REMARK 500 TYR B 209 52.93 -111.25 REMARK 500 GLU B 219 78.13 46.93 REMARK 500 ALA B 221 -21.75 72.27 REMARK 500 TRP B 269 -67.95 -93.25 REMARK 500 ASN B 369 59.09 37.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A2031 DISTANCE = 6.02 ANGSTROMS REMARK 525 HOH B2053 DISTANCE = 5.81 ANGSTROMS REMARK 525 HOH B2111 DISTANCE = 5.83 ANGSTROMS REMARK 525 HOH B2246 DISTANCE = 6.10 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1CB2 RELATED DB: PDB REMARK 900 CELLOBIOHYDROLASE II, CATALYTIC DOMAIN, MUTANT Y169F REMARK 900 RELATED ID: 1HGW RELATED DB: PDB REMARK 900 CEL6A D175A MUTANT REMARK 900 RELATED ID: 1HGY RELATED DB: PDB REMARK 900 CEL6A D221A MUTANT REMARK 900 RELATED ID: 1QJW RELATED DB: PDB REMARK 900 CEL6A (Y169F) WITH A NON-HYDROLYSABLE CELLOTETRAOSE REMARK 900 RELATED ID: 1QK0 RELATED DB: PDB REMARK 900 CEL6A (Y169F) WITH A NON-HYDROLYSABLE CELLOTETRAOSE REMARK 900 RELATED ID: 1QK2 RELATED DB: PDB REMARK 900 WILD TYPE CEL6A WITH A NON-HYDROLYSABLE CELLOTETRAOSE REMARK 900 RELATED ID: 3CBH RELATED DB: PDB REMARK 900 RELATED ID: 4AU0 RELATED DB: PDB REMARK 900 HYPOCREA JECORINA CEL6A D221A MUTANT SOAKED WITH 6- CHLORO-4- REMARK 900 METHYLUMBELLIFERYL-BELTA-D-CELLOBIOSIDE REMARK 900 RELATED ID: 4AX7 RELATED DB: PDB REMARK 900 HYPOCREA JECORINA CEL6A D221A MUTANT SOAKED WITH 4- REMARK 900 METHYLUMBELLIFERYL-BETA-D-CELLOBIOSIDE DBREF 4AX6 A 85 447 UNP P07987 GUX2_HYPJE 109 471 DBREF 4AX6 B 85 447 UNP P07987 GUX2_HYPJE 109 471 SEQADV 4AX6 ALA A 221 UNP P07987 ASP 245 ENGINEERED MUTATION SEQADV 4AX6 ALA B 221 UNP P07987 ASP 245 ENGINEERED MUTATION SEQRES 1 A 363 THR ALA THR TYR SER GLY ASN PRO PHE VAL GLY VAL THR SEQRES 2 A 363 PRO TRP ALA ASN ALA TYR TYR ALA SER GLU VAL SER SER SEQRES 3 A 363 LEU ALA ILE PRO SER LEU THR GLY ALA MET ALA THR ALA SEQRES 4 A 363 ALA ALA ALA VAL ALA LYS VAL PRO SER PHE MET TRP LEU SEQRES 5 A 363 ASP THR LEU ASP LYS THR PRO LEU MET GLU GLN THR LEU SEQRES 6 A 363 ALA ASP ILE ARG THR ALA ASN LYS ASN GLY GLY ASN TYR SEQRES 7 A 363 ALA GLY GLN PHE VAL VAL TYR ASP LEU PRO ASP ARG ASP SEQRES 8 A 363 CYS ALA ALA LEU ALA SER ASN GLY GLU TYR SER ILE ALA SEQRES 9 A 363 ASP GLY GLY VAL ALA LYS TYR LYS ASN TYR ILE ASP THR SEQRES 10 A 363 ILE ARG GLN ILE VAL VAL GLU TYR SER ASP ILE ARG THR SEQRES 11 A 363 LEU LEU VAL ILE GLU PRO ALA SER LEU ALA ASN LEU VAL SEQRES 12 A 363 THR ASN LEU GLY THR PRO LYS CYS ALA ASN ALA GLN SER SEQRES 13 A 363 ALA TYR LEU GLU CYS ILE ASN TYR ALA VAL THR GLN LEU SEQRES 14 A 363 ASN LEU PRO ASN VAL ALA MET TYR LEU ASP ALA GLY HIS SEQRES 15 A 363 ALA GLY TRP LEU GLY TRP PRO ALA ASN GLN ASP PRO ALA SEQRES 16 A 363 ALA GLN LEU PHE ALA ASN VAL TYR LYS ASN ALA SER SER SEQRES 17 A 363 PRO ARG ALA LEU ARG GLY LEU ALA THR ASN VAL ALA ASN SEQRES 18 A 363 TYR ASN GLY TRP ASN ILE THR SER PRO PRO SER TYR THR SEQRES 19 A 363 GLN GLY ASN ALA VAL TYR ASN GLU LYS LEU TYR ILE HIS SEQRES 20 A 363 ALA ILE GLY PRO LEU LEU ALA ASN HIS GLY TRP SER ASN SEQRES 21 A 363 ALA PHE PHE ILE THR ASP GLN GLY ARG SER GLY LYS GLN SEQRES 22 A 363 PRO THR GLY GLN GLN GLN TRP GLY ASP TRP CYS ASN VAL SEQRES 23 A 363 ILE GLY THR GLY PHE GLY ILE ARG PRO SER ALA ASN THR SEQRES 24 A 363 GLY ASP SER LEU LEU ASP SER PHE VAL TRP VAL LYS PRO SEQRES 25 A 363 GLY GLY GLU CYS ASP GLY THR SER ASP SER SER ALA PRO SEQRES 26 A 363 ARG PHE ASP SER HIS CYS ALA LEU PRO ASP ALA LEU GLN SEQRES 27 A 363 PRO ALA PRO GLN ALA GLY ALA TRP PHE GLN ALA TYR PHE SEQRES 28 A 363 VAL GLN LEU LEU THR ASN ALA ASN PRO SER PHE LEU SEQRES 1 B 363 THR ALA THR TYR SER GLY ASN PRO PHE VAL GLY VAL THR SEQRES 2 B 363 PRO TRP ALA ASN ALA TYR TYR ALA SER GLU VAL SER SER SEQRES 3 B 363 LEU ALA ILE PRO SER LEU THR GLY ALA MET ALA THR ALA SEQRES 4 B 363 ALA ALA ALA VAL ALA LYS VAL PRO SER PHE MET TRP LEU SEQRES 5 B 363 ASP THR LEU ASP LYS THR PRO LEU MET GLU GLN THR LEU SEQRES 6 B 363 ALA ASP ILE ARG THR ALA ASN LYS ASN GLY GLY ASN TYR SEQRES 7 B 363 ALA GLY GLN PHE VAL VAL TYR ASP LEU PRO ASP ARG ASP SEQRES 8 B 363 CYS ALA ALA LEU ALA SER ASN GLY GLU TYR SER ILE ALA SEQRES 9 B 363 ASP GLY GLY VAL ALA LYS TYR LYS ASN TYR ILE ASP THR SEQRES 10 B 363 ILE ARG GLN ILE VAL VAL GLU TYR SER ASP ILE ARG THR SEQRES 11 B 363 LEU LEU VAL ILE GLU PRO ALA SER LEU ALA ASN LEU VAL SEQRES 12 B 363 THR ASN LEU GLY THR PRO LYS CYS ALA ASN ALA GLN SER SEQRES 13 B 363 ALA TYR LEU GLU CYS ILE ASN TYR ALA VAL THR GLN LEU SEQRES 14 B 363 ASN LEU PRO ASN VAL ALA MET TYR LEU ASP ALA GLY HIS SEQRES 15 B 363 ALA GLY TRP LEU GLY TRP PRO ALA ASN GLN ASP PRO ALA SEQRES 16 B 363 ALA GLN LEU PHE ALA ASN VAL TYR LYS ASN ALA SER SER SEQRES 17 B 363 PRO ARG ALA LEU ARG GLY LEU ALA THR ASN VAL ALA ASN SEQRES 18 B 363 TYR ASN GLY TRP ASN ILE THR SER PRO PRO SER TYR THR SEQRES 19 B 363 GLN GLY ASN ALA VAL TYR ASN GLU LYS LEU TYR ILE HIS SEQRES 20 B 363 ALA ILE GLY PRO LEU LEU ALA ASN HIS GLY TRP SER ASN SEQRES 21 B 363 ALA PHE PHE ILE THR ASP GLN GLY ARG SER GLY LYS GLN SEQRES 22 B 363 PRO THR GLY GLN GLN GLN TRP GLY ASP TRP CYS ASN VAL SEQRES 23 B 363 ILE GLY THR GLY PHE GLY ILE ARG PRO SER ALA ASN THR SEQRES 24 B 363 GLY ASP SER LEU LEU ASP SER PHE VAL TRP VAL LYS PRO SEQRES 25 B 363 GLY GLY GLU CYS ASP GLY THR SER ASP SER SER ALA PRO SEQRES 26 B 363 ARG PHE ASP SER HIS CYS ALA LEU PRO ASP ALA LEU GLN SEQRES 27 B 363 PRO ALA PRO GLN ALA GLY ALA TRP PHE GLN ALA TYR PHE SEQRES 28 B 363 VAL GLN LEU LEU THR ASN ALA ASN PRO SER PHE LEU MODRES 4AX6 ASN A 289 ASN GLYCOSYLATION SITE MODRES 4AX6 ASN A 310 ASN GLYCOSYLATION SITE MODRES 4AX6 THR A 87 THR GLYCOSYLATION SITE MODRES 4AX6 THR A 97 THR GLYCOSYLATION SITE MODRES 4AX6 SER A 106 SER GLYCOSYLATION SITE MODRES 4AX6 SER A 109 SER GLYCOSYLATION SITE MODRES 4AX6 SER A 110 SER GLYCOSYLATION SITE MODRES 4AX6 SER A 115 SER GLYCOSYLATION SITE MODRES 4AX6 THR A 122 THR GLYCOSYLATION SITE MODRES 4AX6 ASN B 289 ASN GLYCOSYLATION SITE MODRES 4AX6 ASN B 310 ASN GLYCOSYLATION SITE MODRES 4AX6 THR B 97 THR GLYCOSYLATION SITE MODRES 4AX6 SER B 109 SER GLYCOSYLATION SITE MODRES 4AX6 SER B 110 SER GLYCOSYLATION SITE MODRES 4AX6 SER B 115 SER GLYCOSYLATION SITE MODRES 4AX6 THR B 122 THR GLYCOSYLATION SITE HET BGC C 1 11 HET BGC C 2 11 HET BGC D 1 11 HET BGC D 2 11 HET NAG A 501 14 HET NAG A 502 14 HET MAN A 503 11 HET MAN A 504 11 HET MAN A 505 11 HET MAN A 506 11 HET MAN A 507 11 HET MAN A 508 11 HET MAN A 509 11 HET UWU A 600 19 HET NAG B 501 14 HET NAG B 502 14 HET MAN B 504 11 HET MAN B 506 11 HET MAN B 507 11 HET MAN B 508 11 HET MAN B 509 11 HET UWU B 600 19 HETNAM BGC BETA-D-GLUCOPYRANOSE HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM MAN ALPHA-D-MANNOPYRANOSE HETNAM UWU 6-CHLORANYL-7-OXIDANYL-4-PHENYL-CHROMEN-2-ONE HETSYN BGC BETA-D-GLUCOSE; D-GLUCOSE; GLUCOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE HETSYN MAN ALPHA-D-MANNOSE; D-MANNOSE; MANNOSE FORMUL 3 BGC 4(C6 H12 O6) FORMUL 5 NAG 4(C8 H15 N O6) FORMUL 7 MAN 12(C6 H12 O6) FORMUL 14 UWU 2(C15 H9 CL O3) FORMUL 23 HOH *544(H2 O) HELIX 1 1 ASN A 101 ALA A 112 1 12 HELIX 2 2 ILE A 113 LEU A 116 5 4 HELIX 3 3 GLY A 118 ALA A 128 1 11 HELIX 4 4 THR A 138 ASP A 140 5 3 HELIX 5 5 LYS A 141 ASN A 158 1 18 HELIX 6 6 SER A 186 ASP A 189 5 4 HELIX 7 7 GLY A 190 TYR A 209 1 20 HELIX 8 8 ALA A 221 ASN A 229 1 9 HELIX 9 9 THR A 232 ASN A 237 1 6 HELIX 10 10 ALA A 238 LEU A 253 1 16 HELIX 11 11 TRP A 272 ALA A 290 1 19 HELIX 12 12 PRO A 315 GLN A 319 5 5 HELIX 13 13 ASN A 325 HIS A 340 1 16 HELIX 14 14 ASP A 412 LEU A 417 5 6 HELIX 15 15 PHE A 431 ASN A 441 1 11 HELIX 16 16 ASN B 101 ALA B 112 1 12 HELIX 17 17 ILE B 113 LEU B 116 5 4 HELIX 18 18 GLY B 118 ALA B 128 1 11 HELIX 19 19 THR B 138 ASP B 140 5 3 HELIX 20 20 LYS B 141 ASN B 158 1 18 HELIX 21 21 SER B 186 ASP B 189 5 4 HELIX 22 22 GLY B 190 TYR B 209 1 20 HELIX 23 23 ALA B 221 ASN B 229 1 9 HELIX 24 24 THR B 232 ASN B 237 1 6 HELIX 25 25 ALA B 238 LEU B 253 1 16 HELIX 26 26 ASN B 275 ALA B 290 1 16 HELIX 27 27 PRO B 315 GLN B 319 5 5 HELIX 28 28 ASN B 325 HIS B 340 1 16 HELIX 29 29 ASP B 412 LEU B 417 5 6 HELIX 30 30 PHE B 431 ASN B 441 1 11 SHEET 1 AA 2 THR A 97 PRO A 98 0 SHEET 2 AA 2 TYR A 162 VAL A 168 1 N ALA A 163 O THR A 97 SHEET 1 AB 2 MET A 134 LEU A 136 0 SHEET 2 AB 2 TYR A 162 VAL A 168 -1 O GLN A 165 N MET A 134 SHEET 1 AC 7 LEU A 388 VAL A 392 0 SHEET 2 AC 7 PHE A 346 ASP A 350 1 O PHE A 347 N ASP A 389 SHEET 3 AC 7 LEU A 296 THR A 301 1 O ARG A 297 N PHE A 346 SHEET 4 AC 7 VAL A 258 ASP A 263 1 O MET A 260 N GLY A 298 SHEET 5 AC 7 THR A 214 ILE A 218 1 O THR A 214 N ALA A 259 SHEET 6 AC 7 TYR A 162 VAL A 168 1 O GLY A 164 N LEU A 215 SHEET 7 AC 7 MET A 134 LEU A 136 -1 O MET A 134 N VAL A 167 SHEET 1 AD 7 LEU A 388 VAL A 392 0 SHEET 2 AD 7 PHE A 346 ASP A 350 1 O PHE A 347 N ASP A 389 SHEET 3 AD 7 LEU A 296 THR A 301 1 O ARG A 297 N PHE A 346 SHEET 4 AD 7 VAL A 258 ASP A 263 1 O MET A 260 N GLY A 298 SHEET 5 AD 7 THR A 214 ILE A 218 1 O THR A 214 N ALA A 259 SHEET 6 AD 7 TYR A 162 VAL A 168 1 O GLY A 164 N LEU A 215 SHEET 7 AD 7 THR A 97 PRO A 98 1 O THR A 97 N ALA A 163 SHEET 1 BA 2 THR B 97 PRO B 98 0 SHEET 2 BA 2 TYR B 162 VAL B 168 1 N ALA B 163 O THR B 97 SHEET 1 BB 2 MET B 134 LEU B 136 0 SHEET 2 BB 2 TYR B 162 VAL B 168 -1 O GLN B 165 N MET B 134 SHEET 1 BC 7 LEU B 388 VAL B 392 0 SHEET 2 BC 7 PHE B 346 ASP B 350 1 O PHE B 347 N ASP B 389 SHEET 3 BC 7 LEU B 296 THR B 301 1 O ARG B 297 N PHE B 346 SHEET 4 BC 7 VAL B 258 ASP B 263 1 O MET B 260 N GLY B 298 SHEET 5 BC 7 THR B 214 ILE B 218 1 O THR B 214 N ALA B 259 SHEET 6 BC 7 TYR B 162 VAL B 168 1 O GLY B 164 N LEU B 215 SHEET 7 BC 7 MET B 134 LEU B 136 -1 O MET B 134 N VAL B 167 SHEET 1 BD 7 LEU B 388 VAL B 392 0 SHEET 2 BD 7 PHE B 346 ASP B 350 1 O PHE B 347 N ASP B 389 SHEET 3 BD 7 LEU B 296 THR B 301 1 O ARG B 297 N PHE B 346 SHEET 4 BD 7 VAL B 258 ASP B 263 1 O MET B 260 N GLY B 298 SHEET 5 BD 7 THR B 214 ILE B 218 1 O THR B 214 N ALA B 259 SHEET 6 BD 7 TYR B 162 VAL B 168 1 O GLY B 164 N LEU B 215 SHEET 7 BD 7 THR B 97 PRO B 98 1 O THR B 97 N ALA B 163 SSBOND 1 CYS A 176 CYS A 235 1555 1555 2.04 SSBOND 2 CYS A 368 CYS A 415 1555 1555 2.03 SSBOND 3 CYS B 176 CYS B 235 1555 1555 2.03 SSBOND 4 CYS B 368 CYS B 415 1555 1555 2.03 LINK OG1 THR A 87 C1 MAN A 503 1555 1555 1.44 LINK OG1 THR A 97 C1 MAN A 504 1555 1555 1.45 LINK OG SER A 106 C1 MAN A 505 1555 1555 1.45 LINK OG SER A 109 C1 MAN A 506 1555 1555 1.44 LINK OG SER A 110 C1 MAN A 507 1555 1555 1.44 LINK OG SER A 115 C1 MAN A 508 1555 1555 1.44 LINK OG1 THR A 122 C1 MAN A 509 1555 1555 1.44 LINK ND2 ASN A 289 C1 NAG A 501 1555 1555 1.44 LINK ND2 ASN A 310 C1 NAG A 502 1555 1555 1.44 LINK O7 UWU A 600 C1 BGC C 1 1555 1555 1.46 LINK OG1 THR B 97 C1 MAN B 504 1555 1555 1.44 LINK OG SER B 109 C1 MAN B 506 1555 1555 1.44 LINK OG SER B 110 C1 MAN B 507 1555 1555 1.44 LINK OG SER B 115 C1 MAN B 508 1555 1555 1.44 LINK OG1 THR B 122 C1 MAN B 509 1555 1555 1.45 LINK ND2 ASN B 289 C1 NAG B 501 1555 1555 1.44 LINK ND2 ASN B 310 C1 NAG B 502 1555 1555 1.44 LINK O7 UWU B 600 C1 BGC D 1 1555 1555 1.47 LINK O4 BGC C 1 C1 BGC C 2 1555 1555 1.45 LINK O4 BGC D 1 C1 BGC D 2 1555 1555 1.45 CISPEP 1 GLN A 357 PRO A 358 0 -3.67 CISPEP 2 GLN A 422 PRO A 423 0 -2.64 CISPEP 3 ASN A 443 PRO A 444 0 3.18 CISPEP 4 GLN B 357 PRO B 358 0 -0.32 CISPEP 5 GLN B 422 PRO B 423 0 1.69 CISPEP 6 ASN B 443 PRO B 444 0 2.38 CRYST1 49.540 52.960 66.540 77.33 78.60 75.66 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020186 -0.005160 -0.003196 0.00000 SCALE2 0.000000 0.019489 -0.003554 0.00000 SCALE3 0.000000 0.000000 0.015584 0.00000